Search results for "Cardiovascular events"
Adding colchicine after MI may reduce cardiovascular events
While a trial found that low-dose colchicine reduced cardiovascular events after myocardial infarction (MI) significantly more than placebo, there are unresolved questions about inflammation as a therapeutic target, an accompanying editorial noted.
https://immattersacp.org/weekly/archives/2019/11/26/1.htm
26 Nov 2019
Subclinical hypothyroidism prompts personalized decisions
For diagnosing and managing subclinical hypothyroidism, clinical context such as age and symptoms matter, even in the face of an incomplete understanding of the condition.
https://immattersacp.org/archives/2021/02/subclinical-hypothyroidism-prompts-personalized-decisions.htm
1 Feb 2021
Preprocedural statins reduce risk of postprocedure cardiovascular events
Tiotropium improves asthma symptoms as well as salmeterol
https://immattersacp.org/weekly/archives/2010/09/28/5.htm
28 Sep 2010
Latest updates on ACP's priorities, initiatives
ACP Spotlight offers readers a look at ACP's current top priorities and initiatives, as well as highlights from our e-newsletter, ACP Internist Weekly.
https://immattersacp.org/archives/2021/07/latest-updates-on-acps-priorities-initiatives.htm
1 Jul 2021
FDA announces draft guidance for industry on reduction of sodium
The FDA draft guidance provides target short- and long-term mean and upper bound sodium concentrations for food categories and is particularly aimed at national and regional restaurant chains and food manufacturers whose products make up a significant proportion of national sales.
https://immattersacp.org/weekly/archives/2016/06/07/1.htm
7 Jun 2016
Adding ezetimibe to statins in ACS may improve cardiovascular outcomes
Reduction of LDL cholesterol levels may explain the effect of statins on coronary heart disease.
https://immattersacp.org/weekly/archives/2015/06/09/2.htm
9 Jun 2015
Cardiovascular safety of febuxostat and allopurinol compared in patients with gout and CVD
In a modified intention-to-treat analysis, the primary end point of first occurrence of cardiovascular death, nonfatal myocardial infarction, nonfatal stroke, or urgent revascularization for unstable angina occurred in 10.8% of patients taking febuxostat and in 10.4% of patients taking allopurinol (hazard ratio, 1.03).
https://immattersacp.org/weekly/archives/2018/03/20/4.htm
20 Mar 2018
Analyses from SPRINT examine cost-effectiveness, patient-reported outcomes with intensive BP control
The first analysis used a microsimulation model to apply findings from SPRINT to a hypothetical cohort of eligible patients. The second compared patient-reported outcomes from SPRINT in the intensive versus the standard treatment group.
https://immattersacp.org/weekly/archives/2017/08/29/2.htm
29 Aug 2017
Statins' effects on men and women compared
Statin therapy reduced women's risk of cardiovascular events but did not significantly affect mortality or stroke risks in a recent meta-analysis.
https://immattersacp.org/weekly/archives/2012/07/03/2.htm
3 Jul 2012
Between-arm differences in systolic blood pressure may indicate increased mortality risk in hypertension
Patients with hypertension who have a between-arm difference of at least 10 mm Hg in systolic blood pressure may be at higher risk for cardiovascular events and death, according to a new study.
https://immattersacp.org/weekly/archives/2012/03/27/4.htm
27 Mar 2012